GLP-1s: 8 things hospital leaders should know beckershospitalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from beckershospitalreview.com Daily Mail and Mail on Sunday newspapers.
Surgeons and health system leaders are voicing concerns about the unknown long-term risks of GLP-1 receptor agonists, such as Ozempic, Wegovy and Saxenda.
Amid the minimal data, physicians have conflicting opinions about stopping GLP-1 regimens before surgeries. The American Society of Anesthesiologists and the American Gastroenterological Association weigh in.